Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia (Q43971962)

28 November 2017

title

Guidelines for the measurement of BCR-ABL1 transcripts in chronic myeloid leukaemia (English)

1 reference

28 November 2017

1 reference

23

1 reference

28 November 2017

Letizia Foroni

1

1 reference

28 November 2017

Gill Wilson

2

1 reference

28 November 2017

Gareth Gerrard

3

1 reference

28 November 2017

Joanne Mason

4

1 reference

28 November 2017

David Grimwade

5

1 reference

28 November 2017

Helen E White

6

1 reference

28 November 2017

David Gonzalez de Castro

7

1 reference

28 November 2017

Stephen Austin

8

1 reference

28 November 2017

Abida Awan

9

1 reference

28 November 2017

Emma Burt

10

1 reference

28 November 2017

Tim Clench

11

1 reference

28 November 2017

Joanna Farruggia

12

1 reference

28 November 2017

Jeremy Hancock

13

1 reference

28 November 2017

Alexandra E Irvine

14

1 reference

28 November 2017

Aytug Kizilors

15

1 reference

28 November 2017

Stephen Langabeer

16

1 reference

28 November 2017

Benedict J Milner

17

1 reference

28 November 2017

Guillermina Nickless

18

1 reference

28 November 2017

Anna Schuh

19

1 reference

28 November 2017

Anne Sproul

20

1 reference

28 November 2017

Lihui Wang

21

1 reference

28 November 2017

Caroline Wickham

22

1 reference

28 November 2017

language of work or name

English

0 references

publication date

8 March 2011

1 reference

British Journal of Haematology

28 November 2017

published in

1 reference

28 November 2017

volume

153

1 reference

28 November 2017

issue

2

1 reference

28 November 2017

page(s)

179-190

1 reference

Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet

28 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Rationale for the recommendations for harmonizing current methodology for detecting BCR-ABL transcripts in patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Desirable performance characteristics for BCR-ABL measurement on an international reporting scale to allow consistent interpretation of individual patient response and comparison of response rates between clinical trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Standardisation of molecular monitoring for chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Technical aspects and clinical applications of measuring BCR-ABL1 transcripts number in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Monitoring CML patients responding to treatment with tyrosine kinase inhibitors: review and recommendations for harmonizing current methodology for detecting BCR-ABL transcripts and kinase domain mutations and for expressing results

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Dasatinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Diagnosis of chronic myeloid and acute lymphocytic leukemias by detection of leukemia-specific mRNA sequences amplified in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Resistance to imatinib mesylate in chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

In vitro activity of Bcr-Abl inhibitors AMN107 and BMS-354825 against clinically relevant imatinib-resistant Abl kinase domain mutants

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Nilotinib versus imatinib for newly diagnosed chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Differential stability of control gene and fusion gene transcripts over time may hamper accurate quantification of minimal residual disease--a study within the Europe Against Cancer Program

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Establishment of the first World Health Organization International Genetic Reference Panel for quantitation of BCR-ABL mRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

A multiplex PCR for improved detection of typical and atypical BCR–ABL fusion transcripts

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

Fused transcript of abl and bcr genes in chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111/J.1365-2141.2011.08603.X

10.1111/J.1365-2141.2011.08603.X

21 January 2018

Identifiers

DOI

1 reference

28 November 2017

1 reference